Scientific Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
June 13, 2023 | Manuscript
Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma
May 30, 2023 | Manuscript
Ultrasensitive ctDNA MRD Monitoring in early stage lung cancer with PhasED-Seq
April 20, 2023 | Poster
Ultrasensitive Detection of Circulating Tumor DNA In Untreated Diffuse Large B-cell Lymphoma
April 4, 2023 | Poster
Polatuzumab vedotin with dose-adjusted etoposide, cyclophosphamide, doxorubicin, and rituximab (Pola-DA-EPCH-R) for upfront treatment of aggressive B-cell non-Hodgkin lymphomas.
March 9, 2023 | Poster
Ultrasensitive Circulating Tumor DNA (ctDNA) Dynamics after Autologous CD30.CAR-T Cell Therapy for Relapsed or Refractory (r/r) Classical Hodgkin Lymphoma (CHARIOT Trial)
March 9, 2023 | Presentation